Elutia (ELUT) Net Equity Issued and Repurchased (2020 - 2025)
Elutia (ELUT) reported Net Equity Issued and Repurchased of $13.8 million for Q1 2025, up 359.87% sequentially from $3.0 million in Q3 2020.
Elutia (ELUT) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
Elutia (ELUT) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $13.8 million in Q1 2025.
- For the quarter ending Q1 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $13.8 million; the trailing twelve-month figure through Sep 2025 stood at $13.8 million (up 359.87% YoY), and the FY2020 full-year result was $3.4 million, up 50.66% from the prior year.
- Net Equity Issued and Repurchased climbed to $13.8 million in Q1 2025, from $3.0 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $13.8 million in Q1 2025 to a low of $13.8 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 13.80 Mn |
| Mar 31, 2025 | 13.80 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Mar 31, 2020 | 450,000.00 |
| Mar 31, 2020 | 450,000.00 |